Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

PharmEco Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing

Coordinator
Universiteit Gent, Belgium
Runs
1 November 2024 to 31 October 2030
Status
Running
EU funding
€16.0m
Total cost
€34.4m
Partners
54 organisations in 14 countries
Type
Research and Innovation Action
Grant agreement
101165889

What the project is doing

In the project's own words, from its summary on CORDIS.

PHARMECO is supported by the Innovative Health Initiative Joint Undertaking (IHI JU). The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe. The project's overall objective is to revolutionize pharmaceutical manufacturing towards sustainability by integrating environmentally friendly technologies/processes and harmonized sustainability assessments methods into healthcare industry practices.

This encompasses early design phase, operation, and eventual use and disposal. The project's first objective is to enhance the early-stage development of pharmaceutical products by implementing Sustainable-by-Design (SSbD)-driven process-intensified platforms (e.g. continuous manufacturing). This involves designing sustainable processes based on so-called SELECT (Safety, Environment, Legal, Economy, Control and Throughput) criteria and setting up eco-friendly systems for producing small molecules, peptides, oligo-nucleotides, proteins and ribonucleic acid (RNA) with advanced control measures.

Next, PHARMECO aims to scale up and demonstrate environmentally-friendly processes for industrial manufacturing and decontamination, which includes creating infrastructure for studying key unit operations with sustainable technology and for SSbD-driven process intensified manufacture at a scale sufficient for clinical testing and a manufacturing process that is easily transferred to a Good Manufacturing Practice (GMP) environment.

PHARMECO also aims to steer the development of (bio)manufacturing processes towards sustainable production through digital decision-making tools. This involves creating a modular digital tool for assessing sustainability from multiple perspectives, evaluating practices. Finally, the project seeks to establish a standardized approach for assessing the environmental sustainability of pharmaceuticals, which involves collaboration with various stakeholders to create scientifically robust guidelines, applying consistent Life Cycle Assessment (LCA) methodologies, and facilitate regulatory adoption of standardized LCA practices.

By integrating sustainability considerations into every phase of manufacturing, PHARMECO will positively revolutionize pharmaceutical industry.

Topics

Who is involved

OrganisationCityCountryRole
Universiteit GentGentBelgiumCoordinator
Microinnova Engineering GmbHAllerheiligen bei WildonAustriaParticipant
Research Center Pharmaceutical Engineering GmbHGrazAustriaParticipant
Universitaet GrazGrazAustriaParticipant
Janssen Pharmaceutica NVBeerseBelgiumParticipant
Swiftpharma BVGentBelgiumParticipant
Ucb BiopharmaBruxelles / BrusselBelgiumParticipant
Vtu Engineering Belgium BVMechelenBelgiumParticipant
Ares Trading SACoinsinsSwitzerlandAssociatedpartner
Ucb Farchim SABulleSwitzerlandAssociatedpartner
Abbvie Deutschland GmbH & Co KgWiesbadenGermanyAssociatedpartner
Boehringer Ingelheim InternationalgmbhIngelheimGermanyParticipant
Boehringer Ingelheim Pharma GmbH &co KgIngelheimGermanyAssociatedpartner
Merck Electronics KgaaDarmstadtGermanyAssociatedpartner
Merck Healthcare KgaaDarmstadtGermanyAssociatedpartner
Merck Kommanditgesellschaft Auf AktienDarmstadtGermanyParticipant
Merck Life Science KgaaDarmstadtGermanyAssociatedpartner
Sanofi-Aventis Deutschland GmbHFrankfurt Am MainGermanyParticipant
Technische Universitat BerlinBerlinGermanyParticipant
UCB BioSciences GMBHMonheim am RheinGermanyAssociatedpartner
Novo Nordisk A/sBagsvaerdDenmarkParticipant
Aimplas - Asociacion De Investigacion De Materiales Plasticos Y ConexasPaternaSpainParticipant
Cultzyme SLDonostia - San SebastianSpainParticipant
BenkeiLyonFranceParticipant
Institut De Recherches Internationales ServierGif-Sur-YvetteFranceParticipant
Oril IndustrieBolbecFranceAssociatedpartner
Sanofi Winthrop IndustrieGentillyFranceAssociatedpartner
Sanofi-Aventis Recherche & DeveloppementGentillyFranceAssociatedpartner
Sfe ProcessVillers-Les-NancyFranceParticipant
Sofradim Production SasuTrevouxFranceParticipant
Pfizer Ireland PharmaceuticalsCorkIrelandAssociatedpartner
Pfizer Healthcare India Private LimitedTamilNaduIndiaAssociatedpartner
Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.Colleretto GiacosaItalyAssociatedpartner
Merck Serono SpARomaItalyAssociatedpartner
Pfizer Italia s.r.l.LatinaItalyAssociatedpartner
Rijksinstituut Voor Volksgezondheid En Milieu (rivm)BilthovenNetherlandsParticipant
Stichting Radboud UniversiteitNijmegenNetherlandsParticipant
Ucb Pharma B.v.BredaNetherlandsAssociatedpartner
Lifeclean International ABUddevallaSwedenParticipant
Rise Processum ABOrnskoldsvikSwedenParticipant
Rise Research Institutes of Sweden ABBorasSwedenParticipant
Astrazeneca UK LimitedCambridgeUnited KingdomParticipant
Biotoolomics LimitedConsettUnited KingdomAssociatedpartner
Centre for Process Innovation Limited LbgRedcar ClevelandUnited KingdomAssociatedpartner
Glaxosmithkline Research & Development LimitedLondonUnited KingdomParticipant
Loughborough UniversityLoughboroughUnited KingdomAssociatedpartner
Pfizer LimitedSandwichUnited KingdomAssociatedpartner
Pfizer R&D UK LimitedSandwichUnited KingdomAssociatedpartner
UCB celltech pharmaceuticalsSloughUnited KingdomAssociatedpartner
Abbvie IncNorth Chicago IlUnited StatesParticipant
AstraZeneca Pharmaceuticals LPWilmingtonUnited StatesAssociatedpartner
Pfizer IncNew York CityUnited StatesParticipant
Sanofi GenzymeCambridgeUnited StatesAssociatedpartner
Sanofi US Services Inc.Cambridge, MassachusettsUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI